AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and …
Over the last 12 months, insiders at AtriCure, Inc. have bought $111,250 and sold $589,177 worth of AtriCure, Inc. stock.
On average, over the past 5 years, insiders at AtriCure, Inc. have bought $204,842 and sold $12.51M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Privitera Salvatore (Chief Technical Officer) — $111,250.
The last purchase of 5,000 shares for transaction amount of $111,250 was made by Privitera Salvatore (Chief Technical Officer) on 2024‑05‑30.
2024-08-15 | Sale | director | 3,500 0.0082% | $24.07 | $84,245 | 0.00% | ||
2024-05-30 | Chief Technical Officer | 5,000 0.0103% | $22.25 | $111,250 | +22.47% | |||
2024-05-01 | Sale | Chief Mktg & Strategy Officer | 1,500 0.003% | $24.09 | $36,135 | +5.42% | ||
2024-04-01 | Sale | Chief Mktg & Strategy Officer | 1,500 0.0033% | $30.39 | $45,585 | -12.00% | ||
2024-03-18 | Sale | Chief Legal Officer | 1,885 0.004% | $32.16 | $60,622 | -18.13% | ||
2024-03-12 | Sale | Chief Mktg & Strategy Officer | 1,500 0.0033% | $36.72 | $55,080 | -25.18% | ||
2024-03-05 | Sale | Chief Legal Officer | 8,231 0.0172% | $37.36 | $307,510 | -30.59% | ||
2023-11-01 | Sale | Chief Legal Officer | 1,248 0.0026% | $34.43 | $42,969 | -18.48% | ||
2023-07-26 | Sale | Chief Legal Officer | 3,417 0.008% | $57.09 | $195,077 | -40.50% | ||
2023-06-08 | Sale | director | 713 0.0015% | $47.89 | $34,146 | -25.66% | ||
2023-06-06 | Sale | Chief Legal Officer | 1,422 0.003% | $47.03 | $66,877 | -26.36% | ||
2023-05-26 | Sale | director | 4,313 0.0094% | $47.04 | $202,884 | -22.60% | ||
2023-05-01 | Sale | Chief Legal Officer | 4,417 0.0095% | $44.83 | $198,014 | -16.80% | ||
2022-05-13 | Sale | Chief Human Resources Officer | 3,203 0.007% | $42.69 | $136,736 | -0.84% | ||
2022-04-08 | Sale | Chief Human Resources Officer | 282 0.0006% | $61.59 | $17,368 | -30.04% | ||
2022-03-04 | Sale | Chief Human Resources Officer | 1,409 0.0031% | $67.66 | $95,333 | -35.60% | ||
2022-03-02 | Sale | Chief Human Resources Officer | 3,259 0.0071% | $70.40 | $229,434 | -38.89% | ||
2022-02-11 | Sale | Chief Human Resources Officer | 2,490 0.0057% | $67.97 | $169,245 | -32.51% | ||
2022-01-14 | Sale | Chief Human Resources Officer | 2,719 0.006% | $66.11 | $179,753 | -30.89% | ||
2021-12-10 | Sale | Chief Human Resources Officer | 1,528 0.0035% | $70.88 | $108,305 | -31.51% |
Privitera Salvatore | Chief Technical Officer | 103290 0.2119% | $30.50 | 1 | 11 | |
Discovery Group I, LLC | 10 percent owner | 1621334 3.3256% | $30.50 | 47 | 25 | +15.37% |
ROBARDS KAREN P | director | 288328 0.5914% | $30.50 | 23 | 3 | +76.77% |
Drachman David J | President and CEO | 146000 0.2995% | $30.50 | 4 | 15 | <0.0001% |
Piton Julie A | VP Fin & Admin & CFO | 85922 0.1762% | $30.50 | 1 | 2 | <0.0001% |
The Vanguard Group | $144.59M | 9.82 | 4.75M | -0.27% | -$396,798.48 | <0.01 | |
BlackRock | $128.71M | 8.74 | 4.23M | +0.89% | +$1.13M | <0.01 | |
AllianceBernstein | $111.12M | 7.55 | 3.65M | +7.62% | +$7.87M | 0.04 | |
Champlain Investment Partners, LLC | $81.56M | 5.54 | 2.68M | +27.34% | +$17.51M | 0.47 | |
Fidelity Investments | $75.36M | 5.12 | 2.48M | +3,164.47% | +$73.05M | 0.01 |